NCBI PubMed Central
open access
Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tuning epigenetics to enhance cancer virotherapy.#1039875
- Combining Epigenetic And Immune Therapy to Beat Cancer.#668813
- Measurements of cell viability, colony formation, apoptosis, DNA damage, gene expression and promoter occupancy in head and neck squamous cell carcinoma cells treated with histone lysine demethylase inhibitors and panobinostat#1040353
- Repurposing Bromhexine to Suppress Non-Small Cell Lung Cancer Growth by Inhibiting Methylenetetrahydrofolate dehydrogenase 2 - Dataset#196685
- Additional file 2 of Elucidating the beneficial effects of gut microbiota-derived metabolites in treating hepatocellular carcinoma: an integrated network pharmacology, molecular docking, and single-cell sequencing analysis#780719
Record · ID 148229
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive